MEGAN NACAR
BOARD ADVISOR
VICE PRESIDENT OF COMMERCIAL
Connect with me on
I’m a life sciences executive with 12+ years of experience leading commercial strategy, partnerships, and go-to-market execution across diagnostics, bioinformatics, and emerging technologies in precision medicine.
Currently serving as Vice President of Commercial at DeciBio, I work across therapeutic areas to accelerate access to next-generation diagnostics and therapeutics, including liquid biopsy, AI-enabled imaging, women’s health, and cell and gene therapy. I also serve as Board Advisor to the executive team at Helio Genomics, an early cancer detection liquid biopsy technology for hepatocellular carcinoma.
I’ve built and scaled partnerships with companies like Illumina, IDT, and Pillar Biosciences, and previously led commercial initiatives at Pierian and Velsera. Beyond my work in industry, I serve on the executive council at BLOC (Biopharma Leaders of Color), a 501(c)(3) dedicated to advancing inclusive leadership in healthcare.
Passionate about making science more human, I bring both business rigor and a personal commitment to equity, innovation, and storytelling in healthcare.
Moderating a panel at the Diagnostics & Discovery Summit on the Impact of Universal Germline Testing on precision medicine. Left to right: Megan Nacar, Kevin Haas, Michael Hultner, Ed Esplin MD, Deepak Kapoor MD.
Moderating a panel at BIO 2025's AI Summit Track on AI Applications in Biopharma in partnership with the Alliance for Artificial Intelligence in Healthcare.
Left to right: Alex Zhavoronkov (Insilico Medicine), Maria Luisa Pineda, PhD (Envisagenics), Jason Raeburn (Paul Hastings), Rafael Rosegnarten (Genialis), Megan Nacar (DeciBio), Attila Csikasz-Nagy (Cytocast)
Personalized Medicine Conference at Harvard Medical School 2024. Was invited to speak on a panel discussing the transformation of standard of care imaging in precision diagnostics.
Left to right: Megan Nacar (DeciBio), Angel Alberich (Quibim)
BLOC at BIO 2025 Annual Reception. Presenting the BLOC 100 program.
Clinical
Genomics
Next Generation Sequencing
Colorectal Cancer Alliance
Digital
Pathology
Biopharma Leaders of Color
Tahitian
Dance
Filipino American Community
Hot Vinyasa Yoga
Paddle Tennis
Formula 1